Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers

NCT ID: NCT07097298

Last Updated: 2025-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-31

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to improve quality of life in Parkinson's Disease (PD) patients by increasing their empathy and their (self-)compassion. The main question it aims to answer is:

Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training?

Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease(PD)

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Empathy (self-)compassion Parkinson disease (PD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Empathy and (self-)compassion training

A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion. The training will be designed in order to address both self-compassion and compassion. We expect to conduct 1 session at the beginning and 1 session at the end of the program with exercises to do at home for 6 weeks, assigned as tasks based on the needs of patients and their caregivers

Group Type EXPERIMENTAL

empathy and compassion training

Intervention Type BEHAVIORAL

A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

empathy and compassion training

A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of PD
* Hoehn and Yahr scale, stage ≤ 3
* Mini Mental State Examination with a score ≥ 26
* Able to give informed consent as documented by signature
* At least, secondary school education
* To have a regular caregiver at home


* Taking care of the patient on a regular basis, i.e., at least 3 days per week
* Being caregiver of the patients for at least 3 months
* At least, secondary school education
* Written informed consent

Exclusion Criteria

* Any medical condition that is not PD, such as drug induced parkinsonism
* Major depression, dysthymia, or according to DSM-V
* Other neurological or psychiatric diseases
* Neuropsychological scores compatible with the diagnosis of early dementia
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc

For CAREGIVERS:
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CTU-EOC Clinical Trial Unit Ente Ospedaliero Cantonale

UNKNOWN

Sponsor Role collaborator

Alain Kaelin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alain Kaelin

Prof. MD PhD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC

Lugano, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alain Kaelin, Prof. MD PhD

Role: CONTACT

Phone: +41918117342

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alain Kaelin, Prof. MD PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EMPCOMP-PD-001

Identifier Type: -

Identifier Source: org_study_id